Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 73
1.
Cancer Rep (Hoboken) ; 7(5): e2066, 2024 May.
Article En | MEDLINE | ID: mdl-38703051

BACKGROUND: The tumor microenvironment of solid tumors governs the differentiation of otherwise non-immunosuppressive macrophages and gamma delta (γδ) T cells into strong immunosuppressors while promoting suppressive abilities of known immunosuppressors such as myeloid-derived suppressor cells (MDSCs) upon infiltration into the tumor beds. RECENT FINDINGS: In epithelial malignancies, tumor-associated macrophages (TAMs), precursor monocytic MDSCs (M-MDSCs), and gamma delta (γδ) T cells often acquire strong immunosuppressive abilities that dampen spontaneous immune responses by tumor-infiltrating T cells and B lymphocytes against cancer. Both M-MDSCs and γδ T cells have been associated with worse prognosis for multiple epithelial cancers. CONCLUSION: Here we discuss recent discoveries on how tumor-associated macrophages and precursor M-MDSCs as well as tumor associated-γδ T cells acquire immunosuppressive abilities in the tumor beds, promote cancer metastasis, and perspectives on how possible novel interventions could restore the effective adaptive immune responses in epithelial cancers.


Lymphocytes, Tumor-Infiltrating , Myeloid-Derived Suppressor Cells , Tumor Microenvironment , Humans , Tumor Microenvironment/immunology , Lymphocytes, Tumor-Infiltrating/immunology , Myeloid-Derived Suppressor Cells/immunology , Intraepithelial Lymphocytes/immunology , Neoplasms, Glandular and Epithelial/immunology , Neoplasms, Glandular and Epithelial/pathology , Immune Tolerance , Animals , Tumor-Associated Macrophages/immunology , Receptors, Antigen, T-Cell, gamma-delta/metabolism , Receptors, Antigen, T-Cell, gamma-delta/immunology , Myeloid Cells/immunology
2.
PLoS One ; 19(5): e0303949, 2024.
Article En | MEDLINE | ID: mdl-38805441

Cognitive rehabilitation, STEM (science, technology, engineering, and math) skill acquisition, and coaching games such as chess often require tutoring decision-making strategies. The advancement of AI-driven tutoring systems for facilitating human learning requires an understanding of the impact of evaluative feedback on human decision-making and skill development. To this end, we conduct human experiments using Amazon Mechanical Turk to study the influence of evaluative feedback on human decision-making in sequential tasks. In these experiments, participants solve the Tower of Hanoi puzzle and receive AI-generated feedback while solving it. We examine how this feedback affects their learning and skill transfer to related tasks. Additionally, treating humans as noisy optimal agents, we employ maximum entropy inverse reinforcement learning to analyze the effect of feedback on the implicit human reward structure that guides their decision making. Lastly, we explore various computational models to understand how people incorporate evaluative feedback into their decision-making processes. Our findings underscore that humans perceive evaluative feedback as indicative of their long-term strategic success, thus aiding in skill acquisition and transfer in sequential decision-making tasks. Moreover, we demonstrate that evaluative feedback fosters a more structured and organized learning experience compared to learning without feedback. Furthermore, our results indicate that providing intermediate goals alone does not significantly enhance human learning outcomes.


Decision Making , Learning , Humans , Learning/physiology , Male , Female , Adult , Young Adult , Artificial Intelligence , Reinforcement, Psychology
3.
Sci Rep ; 14(1): 6585, 2024 Mar 19.
Article En | MEDLINE | ID: mdl-38503842

A comparative study between Nitrogen (N2) and Argon (Ar) plasma is carried out to investigate its effect on surface morphology, hydrophilicity, permeate flux and ageing of cellulose nitrate polymeric membranes in the present work. Langmuir probe and Optical Emission Spectroscopy are used to characterize the plasma. The SEM analysis reveals the noticeable macro-void creations and pore enlargement for both N2 and Ar plasma. The AFM analysis shows a higher surface roughness for Ar plasma treatment as compared to N2 plasma treatment. XPS analysis confirms the changes in the polymer matrix along with the incorporation of various functional groups on the membrane surface as a result of the plasma treatment. A better hydrophilic nature with prolonged plasma treatment is observed for Ar plasma as compared to N2 plasma treatment. The present results show a higher permeate flux with a high rejection rate for Ar plasma treatment in comparison to N2 plasma, which might be due to the pore size and pore area enlargement of the membrane. The hydrophobic recovery for both the plasma-treated membranes is found significant for the initial ageing period of 7 days and found almost stable in nature after 7 days. A diffusion-based theoretical model is developed to study the hydrophobic recovery of plasma-treated membranes. A strong alignment between experimental and theoretical results is observed in the present work. The Cake Filtration model, derived from the Hermia model, is identified as the most suitable model for describing the fouling mechanisms for the present work.

5.
Immunity ; 56(11): 2570-2583.e6, 2023 Nov 14.
Article En | MEDLINE | ID: mdl-37909039

Dimeric IgA (dIgA) can move through cells via the IgA/IgM polymeric immunoglobulin receptor (PIGR), which is expressed mainly on mucosal epithelia. Here, we studied the ability of dIgA to target commonly mutated cytoplasmic oncodrivers. Mutation-specific dIgA, but not IgG, neutralized KRASG12D within ovarian carcinoma cells and expelled this oncodriver from tumor cells. dIgA binding changed endosomal trafficking of KRASG12D from accumulation in recycling endosomes to aggregation in the early/late endosomes through which dIgA transcytoses. dIgA targeting of KRASG12D abrogated tumor cell proliferation in cell culture assays. In vivo, KRASG12D-specific dIgA1 limited the growth of KRASG12D-mutated ovarian and lung carcinomas in a manner dependent on CD8+ T cells. dIgA specific for IDH1R132H reduced colon cancer growth, demonstrating effective targeting of a cytoplasmic oncodriver not associated with surface receptors. dIgA targeting of KRASG12D restricted tumor growth more effectively than small-molecule KRASG12D inhibitors, supporting the potential of this approach for the treatment of human cancers.


Carcinoma , Immunoglobulin A , Humans , Immunoglobulin A/metabolism , CD8-Positive T-Lymphocytes/metabolism , Proto-Oncogene Proteins p21(ras)/metabolism , Cytoplasm/metabolism
6.
ACS Omega ; 8(39): 36065-36075, 2023 Oct 03.
Article En | MEDLINE | ID: mdl-37810656

Covalent organic framework (COF) materials have greatly expanded their range in a variety of applications since the cognitive goal of a highly organized and durable adsorbent is quite rational. The characteristics of a conjugated organic framework are combined with an industrially relevant polymer to produce a composite membrane optimized for selectively adsorbing carbon dioxide (CO2) gas across a wide temperature range. Additionally, treatment of the composite membrane with cold atmospheric plasma (CAP) that specifically enhanced the parent membrane's surface area by 36% is established. Following CAP treatment, the membrane accelerates the CO2 uptake by as much as 66%. This is primarily due to a Lewis acid-base interaction between the electron-deficient carbon atom of CO2 and the newly acquired functionalities on the COFs@PVDF membrane's surface. In particular, the C-N bonds, which appear to be a higher electron density site, play a key role in this interaction. Moreover, the empirical model proposed here has confirmed CO2 adsorption phenomena in the COF@PVDF composite membrane, which closely matches the findings from the experimental data set under designated operating conditions. As a result, the current study may pave the way for future design work as well as refine the covalent framework polymer composite membrane's features, revealing a more sophisticated approach to addressing CO2 capture problems.

7.
Blood Adv ; 7(18): 5586-5602, 2023 09 26.
Article En | MEDLINE | ID: mdl-37531660

The pathogenesis of cutaneous T-cell lymphoma (CTCL) remains unclear. Using single-cell RNA or T-cell receptor (TCR) sequencing of 32 619 CD3+CD4+ and CD26+/CD7+ and 29 932 CD3+CD4+ and CD26-/CD7- lymphocytes from the peripheral blood of 7 patients with CTCL, coupled to single-cell ATAC-sequencing of 26,411 CD3+CD4+ and CD26+/CD7+ and 33 841 CD3+CD4+ and CD26-/CD7- lymphocytes, we show that tumor cells in Sézary syndrome and mycosis fungoides (MF) exhibit different phenotypes and trajectories of differentiation. When compared to MF, Sézary cells exhibit narrower repertoires of TCRs and exhibit clonal enrichment. Surprisingly, we identified ≥200 mutations in hematopoietic stem cells from multiple patients with Sézary syndrome. Mutations in key oncogenes were also present in peripheral Sézary cells, which also showed the hallmarks of recent thymic egression. Together our data suggest that CTCL arises from mutated lymphocyte progenitors that acquire TCRs in the thymus, which complete their malignant transformation in the periphery.


Lymphoma, T-Cell, Cutaneous , Mycosis Fungoides , Sezary Syndrome , Skin Neoplasms , Humans , Sezary Syndrome/genetics , Sezary Syndrome/pathology , Dipeptidyl Peptidase 4 , Skin Neoplasms/genetics , Skin Neoplasms/pathology , Mycosis Fungoides/genetics , Mycosis Fungoides/pathology , Lymphoma, T-Cell, Cutaneous/genetics , Receptors, Antigen, T-Cell
8.
Gynecol Oncol ; 173: 114-121, 2023 06.
Article En | MEDLINE | ID: mdl-37121178

OBJECTIVE: To demonstrate that shared antibody responses in endometriosis and endometriosis-associated ovarian cancer spontaneously antagonize malignant progression and can be leveraged to develop future immunotherapies. METHODS: B cells from cyopreserved clear cell ovarian carcinoma (CCC, n = 2), endometrioid ovarian carcinoma (EC, n = 2), and endometriomas (n = 2) were isolated, activated, and EBV-immortalized. Antibodies were purified from B cell supernatants and used for screening arrays containing most of the human proteome. Targets were prioritized based on accessibility (transmembrane or secreted proteins), expression in endometriosis and cancer, and concurrent IgA and IgG responses. We focused on antibodies targeting tumor-promoting syndecan binding protein (SDCBP) to demonstrate anti-tumor activity. Immunoblots and qPCR were performed to assess SDCBP expression in ovarian cancer and endometriosis cell lines and tumor samples. Recombinant IgG4 was generated using the variable heavy and light chains of dominant B cell receptors (BCRs) reacting against the extracellular domain of SDCBP, and used in in vivo studies in human CCC- and high-grade serous ovarian carcinoma (HGSOC)-bearing immunodeficient mice. RESULTS: Nine accessible proteins detected by both IgA and IgG were identified in all samples - including SDCBP, which is expressed in ovarian carcinomas of multiple histologies. Administration of α-SDCBP IgG4 in OVCAR3 (HGSOC), TOV21G and RMG-I (CCC) tumor-bearing mice significantly decreased tumor volume compared to control irrelevant IgG4. CONCLUSIONS: Spontaneous antibody responses exert suboptimal but measurable immune pressure against malignant progression in ovarian carcinomas. Using tumor-derived antibodies for developing novel immunotherapeutics warrants further investigation.


Adenocarcinoma, Clear Cell , Carcinoma, Endometrioid , Endometriosis , Ovarian Neoplasms , Humans , Female , Animals , Mice , Ovarian Neoplasms/pathology , Apoptosis , Antibody Formation , Cell Line, Tumor , Carcinoma, Ovarian Epithelial , Carcinoma, Endometrioid/pathology , Immunoglobulin A/metabolism , Adenocarcinoma, Clear Cell/pathology , Syntenins/metabolism
9.
Inflammation ; 46(4): 1144-1160, 2023 Aug.
Article En | MEDLINE | ID: mdl-37072606

The mammalian Transient Receptor Potential Canonical (TRPC) subfamily comprises seven transmembrane proteins (TRPC1-7) forming cation channels in the plasma membrane of mammalian cells. TRPC channels mediate Ca2+ and Na+ influx into the cells. Amongst TRPCs, TRPC6 deficiency or increased activity due to gain-of-function mutations has been associated with a multitude of diseases, such as kidney disease, pulmonary disease, and neurological disease. Indeed, the TRPC6 protein is expressed in various organs and is involved in diverse signalling pathways. The last decade saw a surge in the investigative studies concerning the physiological roles of TRPC6 and describing the development of new pharmacological tools modulating TRPC6 activity. The current review summarizes the progress achieved in those investigations.


TRPC Cation Channels , Transient Receptor Potential Channels , Animals , TRPC6 Cation Channel/metabolism , TRPC Cation Channels/genetics , TRPC Cation Channels/metabolism , Transient Receptor Potential Channels/metabolism , Signal Transduction , Membrane Proteins/metabolism , Calcium/metabolism , Mammals/metabolism
10.
Org Biomol Chem ; 21(8): 1657-1661, 2023 Feb 22.
Article En | MEDLINE | ID: mdl-36727302

An iron oxide nanocatalyst supported on a potassium exchanged zeolite-Y (Fe2O3-KY) is an efficient and reusable catalyst that promotes the selective α-H functionalization of 2-naphthols with various aromatic primary alcohols. The reaction occurs at 110 °C in dichloroethane and requires 6 h for completion. The product yields were found to vary with respect to the nature of the substituents. Benzyl alcohols with electron-donating groups gave the highest yields of up to 90%.

11.
Semin Immunol ; 65: 101707, 2023 01.
Article En | MEDLINE | ID: mdl-36527759

Immuno-oncology has traditionally focused on the cellular arm of the adaptive immune response, while attributing tumor-promoting activity to humoral responses in tumor-bearing hosts. This view stems from mouse models that do not necessarily recapitulate the antibody response process consistently observed in most human cancers. In recent years, the field has reconsidered the coordinated action of T and B cell responses in the context of anti-tumor immunity, as in any other immune response. Thus, recent studies in human cancer identify B cell responses with better outcome, typically in association with superior T cell responses. An area of particular interest is tertiary lymphoid structures, where germinal centers produce isotype switched antibodies and B cells and T lymphocytes interact with other immune cell types. The presence of these lymphoid structures is associated with better immunotherapeutic responses and remain poorly understood. Here, we discuss recent discoveries on how coordination between humoral and cellular responses is required for effective immune pressure against malignant progression, providing a perspective on the role of tertiary lymphoid structures and interventions to elicit their formation in unresectable tumors.


B-Lymphocytes , Neoplasms , T-Lymphocytes , Tertiary Lymphoid Structures , Animals , Humans , Mice , Adaptive Immunity/immunology , B-Lymphocytes/immunology , Neoplasms/immunology , Neoplasms/therapy , T-Lymphocytes/immunology , Tertiary Lymphoid Structures/immunology
12.
PLoS One ; 17(8): e0272634, 2022.
Article En | MEDLINE | ID: mdl-35930584

BACKGROUND: Child undernutrition is a burden and the leading cause of child mortality in low-and middle-income countries like Bangladesh and India. Currently, this issue is a matter of great concern, inasmuch as achieving the Sustainable Development Goals (SDGs). The study intends to determine the factors of child undernutrition using a single composite index of anthropometric failure (CIAF) among the Bengali population. METHODS: Unit level data on 14055 under 5 children were extracted from the Bangladesh Demographic and Health Survey 2017-18 (BDHS) and the 4th National Family Health Survey of India (NFHS-4). To understand child undernutrition and generate CIAF, data on height-for-age (stunting), weight-for-height (wasting), and weight-for-age (underweight) were used by WHO guidelines. These three undernutrition indicators were combined into a single undernutrition indicator called anthropometric failure (anth-failure) using the CIAF concept. Explanatory factors of anth-failure included data on maternal health, socio-demographic and birth-related variables. Differences of frequency were determined by Z-proportional and Chi-square tests; predictors of anth-failure were determined by binary logistic regression. Cut off point of p-value was taken as 0.05 to test the significance. RESULTS: Inter-country disparities were revealed, about half of Bengali children in India and two-fifths in Bangladesh being prone to anth-failure. Stunting and underweight were more prevalent in both countries than wasting. Maternal undernutrition, lack of maternal education, and poor wealth index were common factors of anth-failure for both countries. Children in Bangladesh developed anth-failure after the end of breastfeeding period, indicating a lack of nutritious food. Lack of antenatal care was another significant factor in Bangladesh. In India, the first child suffered from anth-failure due to lack of maternal education. CONCLUSIONS: This study provides a better understanding of multifactorial impact on child undernutrition. It is proposed that the emphasis should be on initiatives that improve maternal education and nutrition, child food security, boost household wealth index, and enhance mothers' access to health care. The study strongly recommends that the governments of Bangladesh and India invest financially in preventing child malnutrition, which will contribute to achieving the first four SDGs.


Child Nutrition Disorders , Malnutrition , Bangladesh/epidemiology , Child , Child Nutrition Disorders/epidemiology , Female , Growth Disorders/etiology , Humans , India/epidemiology , Infant , Malnutrition/complications , Malnutrition/epidemiology , Pregnancy , Prevalence , Thinness/complications , Thinness/epidemiology
13.
Mol Cancer Ther ; 21(7): 1184-1194, 2022 07 05.
Article En | MEDLINE | ID: mdl-35499393

Although chimeric antigen receptor (CAR)-expressing T cells have proven success in hematologic malignancies, their effectiveness in solid tumors has been largely unsuccessful thus far. We found that some olfactory receptors are expressed in a variety of solid tumors of different histologic subtypes, with a limited pattern of expression in normal tissues. Quantification of OR2H1 expression by qRT-PCR and Western blot analysis of 17 normal tissues, 82 ovarian cancers of various histologies, eight non-small cell lung cancers (NSCLCs), and 17 breast cancers demonstrated widespread OR2H1 expression in solid epithelial tumors with expression in normal human tissues limited to the testis. CAR T cells recognizing the extracellular domain of the olfactory receptor OR2H1 were generated with a targeting motif identified through the screening of a phage display library and demonstrated OR2H1-specific cytotoxic killing in vitro and in vivo, using tumor cells with spontaneous expression of variable OR2H1 levels. Importantly, recombinant OR2H1 IgG generated with the VH/VL sequences of the CAR construct specifically detected OR2H1 protein signal in 60 human lung cancers, 40 ovarian carcinomas, and 73 cholangiocarcinomas, at positivity rates comparable with mRNA expression and without OR2H1 staining in 58 normal tissues. CRISPR/Cas9-mediated ablation of OR2H1 confirmed targeting specificity of the CAR and the tumor-promoting role of OR2H1 in glucose metabolism. Therefore, T cells redirected against OR2H1-expressing tumor cells represent a promising therapy against a broad range of epithelial cancers, likely with an admissible toxicity profile.


Lung Neoplasms , Neoplasms, Glandular and Epithelial , Ovarian Neoplasms , Receptors, Odorant , Female , Humans , Cell Line, Tumor , Immunotherapy, Adoptive , Lung Neoplasms/genetics , Lung Neoplasms/therapy , Neoplasms, Glandular and Epithelial/metabolism , Ovarian Neoplasms/metabolism , Receptors, Odorant/metabolism , T-Lymphocytes
14.
Sensors (Basel) ; 22(7)2022 Mar 25.
Article En | MEDLINE | ID: mdl-35408129

A lightweight on-device liquid consumption estimation system involving an energy-aware machine learning algorithm is developed in this work. This system consists of two separate on-device neural network models that carry out liquid consumption estimation with the result of two tasks: the detection of sip from gestures with which the bottle is handled by its user and the detection of first sips after a bottle refill. This predictive volume estimation framework incorporates a self-correction mechanism that can minimize the error after each bottle fill-up cycle, which makes the system robust to errors from the sip classification module. In this paper, a detailed characterization of sip detection is performed to understand the accuracy-complexity tradeoffs by developing and implementing a variety of different ML models with varying complexities. The maximum energy consumed by the entire framework is around 119 mJ during a maximum computation time of 300 µs. The energy consumption and computation times of the proposed framework is suitable for implementation in low-power embedded hardware that can be incorporated in consumer grade water bottles.


Algorithms , Neural Networks, Computer , Computers , Gestures , Machine Learning
15.
Cancer Cell ; 40(5): 545-557.e13, 2022 05 09.
Article En | MEDLINE | ID: mdl-35427494

Despite repeated associations between T cell infiltration and outcome, human ovarian cancer remains poorly responsive to immunotherapy. We report that the hallmarks of tumor recognition in ovarian cancer-infiltrating T cells are primarily restricted to tissue-resident memory (TRM) cells. Single-cell RNA/TCR/ATAC sequencing of 83,454 CD3+CD8+CD103+CD69+ TRM cells and immunohistochemistry of 122 high-grade serous ovarian cancers shows that only progenitor (TCF1low) tissue-resident T cells (TRMstem cells), but not recirculating TCF1+ T cells, predict ovarian cancer outcome. TRMstem cells arise from transitional recirculating T cells, which depends on antigen affinity/persistence, resulting in oligoclonal, trogocytic, effector lymphocytes that eventually become exhausted. Therefore, ovarian cancer is indeed an immunogenic disease, but that depends on ∼13% of CD8+ tumor-infiltrating T cells (∼3% of CD8+ clonotypes), which are primed against high-affinity antigens and maintain waves of effector TRM-like cells. Our results define the signature of relevant tumor-reactive T cells in human ovarian cancer, which could be applicable to other tumors with unideal mutational burden.


Immunologic Memory , Ovarian Neoplasms , CD8-Positive T-Lymphocytes , Female , Humans , Lymphocytes, Tumor-Infiltrating , Memory T Cells
16.
Immunity ; 55(1): 115-128.e9, 2022 01 11.
Article En | MEDLINE | ID: mdl-35021053

The immune checkpoint receptor PD-1 on T follicular helper (Tfh) cells promotes Tfh:B cell interactions and appropriate positioning within tissues. Here, we examined the impact of regulation of PD-1 expression by the genomic organizer SATB1 on Tfh cell differentiation. Vaccination of CD4CreSatb1f/f mice enriched for antigen-specific Tfh cells, and TGF-ß-mediated repression of SATB1 enhanced Tfh differentiation of human T cells. Mechanistically, high Icos expression in Satb1-/- CD4+ T cells promoted Tfh cell differentiation by preventing T follicular regulatory cell skewing and resulted in increased isotype-switched B cell responses in vivo. Ovarian tumors in CD4CreSatb1f/f mice accumulated tumor antigen-specific, LIGHT+CXCL13+IL-21+ Tfh cells and tertiary lymphoid structures (TLS). TLS formation decreased tumor growth in a CD4+ T cell and CXCL13-dependent manner. The transfer of Tfh cells, but not naive CD4+ T cells, induced TLS at tumor beds and decreased tumor growth. Thus, TGF-ß-mediated silencing of Satb1 licenses Tfh cell differentiation, providing insight into the genesis of TLS within tumors.


Germinal Center/immunology , Lymphocytes, Tumor-Infiltrating/immunology , Matrix Attachment Region Binding Proteins/metabolism , T-Lymphocytes, Helper-Inducer/immunology , Tertiary Lymphoid Structures/immunology , Transforming Growth Factor beta/metabolism , Animals , Cell Differentiation , Gene Expression Regulation , Gene Silencing , Genotype , Matrix Attachment Region Binding Proteins/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Programmed Cell Death 1 Receptor/genetics , Programmed Cell Death 1 Receptor/metabolism , Transforming Growth Factor beta/genetics
17.
Cancer Res ; 82(5): 859-871, 2022 Mar 01.
Article En | MEDLINE | ID: mdl-34949671

Recent studies suggest that B cells could play an important role in the tumor microenvironment. However, the role of humoral responses in endometrial cancer remains insufficiently investigated. Using a cohort of 107 patients with different histological subtypes of endometrial carcinoma, we evaluated the role of coordinated humoral and cellular adaptive immune responses in endometrial cancer. Concomitant accumulation of T, B, and plasma cells at tumor beds predicted better survival. However, only B-cell markers corresponded with prolonged survival specifically in high-grade endometrioid type and serous tumors. Immune protection was associated with class-switched IgA and, to a lesser extent, IgG. Expressions of polymeric immunoglobulin receptor (pIgR) by tumor cells and its occupancy by IgA were superior predictors of outcome and correlated with defects in methyl-directed DNA mismatch repair. Mechanistically, pIgR-dependent, antigen-independent IgA occupancy drove activation of inflammatory pathways associated with IFN and TNF signaling in tumor cells, along with apoptotic and endoplasmic reticulum stress pathways, while thwarting DNA repair mechanisms. Together, these findings suggest that coordinated humoral and cellular immune responses, characterized by IgA:pIgR interactions in tumor cells, determine the progression of human endometrial cancer as well as the potential for effective immunotherapies. SIGNIFICANCE: This study provides new insights into the crucial role of humoral immunity in human endometrial cancer, providing a rationale for designing novel immunotherapies against this prevalent malignancy. See related commentary by Osorio and Zamarin, p. 766.


Endometrial Neoplasms , Receptors, Polymeric Immunoglobulin , B-Lymphocytes/metabolism , Endometrial Neoplasms/pathology , Female , Humans , Immunity, Humoral , Immunoglobulin A/metabolism , Receptors, Polymeric Immunoglobulin/genetics , Receptors, Polymeric Immunoglobulin/metabolism , Tumor Microenvironment
18.
Nature ; 591(7850): 464-470, 2021 03.
Article En | MEDLINE | ID: mdl-33536615

Most ovarian cancers are infiltrated by prognostically relevant activated T cells1-3, yet exhibit low response rates to immune checkpoint inhibitors4. Memory B cell and plasma cell infiltrates have previously been associated with better outcomes in ovarian cancer5,6, but the nature and functional relevance of these responses are controversial. Here, using 3 independent cohorts that in total comprise 534 patients with high-grade serous ovarian cancer, we show that robust, protective humoral responses are dominated by the production of polyclonal IgA, which binds to polymeric IgA receptors that are universally expressed on ovarian cancer cells. Notably, tumour B-cell-derived IgA redirects myeloid cells against extracellular oncogenic drivers, which causes tumour cell death. In addition, IgA transcytosis through malignant epithelial cells elicits transcriptional changes that antagonize the RAS pathway and sensitize tumour cells to cytolytic killing by T cells, which also contributes to hindering malignant progression. Thus, tumour-antigen-specific and -antigen-independent IgA responses antagonize the growth of ovarian cancer by governing coordinated tumour cell, T cell and B cell responses. These findings provide a platform for identifying targets that are spontaneously recognized by intratumoural B-cell-derived antibodies, and suggest that immunotherapies that augment B cell responses may be more effective than approaches that focus on T cells, particularly for malignancies that are resistant to checkpoint inhibitors.


Antigens, Neoplasm/immunology , Immunoglobulin A/immunology , Ovarian Neoplasms/immunology , Ovarian Neoplasms/pathology , T-Lymphocytes, Cytotoxic/immunology , Transcytosis , Antibody Specificity , Antigens, CD/immunology , Cell Line , Disease Progression , Female , Humans , Ovarian Neoplasms/prevention & control , Receptors, Fc/immunology , Signaling Lymphocytic Activation Molecule Family/immunology , Transcytosis/immunology , Tumor Microenvironment/immunology
19.
J Appl Biomech ; 37(3): 215-223, 2021 06 01.
Article En | MEDLINE | ID: mdl-33631718

Impairment of arm movements poststroke often results in the use of compensatory trunk movements to complete motor tasks. These compensatory movements have been mostly observed in tightly controlled conditions, with very few studies examining them in more naturalistic settings. In this study, the authors quantified the presence of compensatory movements during a set of continuous reaching and manipulation tasks performed with both the paretic and nonparetic arm (in 9 chronic stroke survivors) or the dominant arm (in 20 neurologically unimpaired control participants). Kinematic data were collected using motion capture to assess trunk and elbow movement. The authors found that trunk displacement and rotation were significantly higher when using the paretic versus nonparetic arm (P = .03). In contrast, elbow angular displacement was significantly lower in the paretic versus nonparetic arm (P = .01). The reaching tasks required significantly higher trunk compensation and elbow movement than the manipulation tasks. These results reflect increased reliance on compensatory trunk movements poststroke, even in everyday functional tasks, which may be a target for home rehabilitation programs. This study provides a novel contribution to the rehabilitation literature by examining the presence of compensatory movements in naturalistic reaching and manipulation tasks.


Stroke Rehabilitation , Stroke , Arm , Biomechanical Phenomena , Humans , Movement , Survivors , Torso
20.
J Clin Invest ; 131(3)2021 02 01.
Article En | MEDLINE | ID: mdl-33270606

Cutaneous T cell lymphoma (CTCL) has a poorly understood etiology and no known cure. Using conditional knockout mice, we found that ablation of the genomic organizer special AT-rich sequence-binding protein 1 (Satb1) caused malignant transformation of mature, skin-homing, Notch-activated CD4+ and CD8+ T cells into progressively fatal lymphoma. Mechanistically, Satb1 restrained Stat5 phosphorylation and the expression of skin-homing chemokine receptors in mature T cells. Notably, methyltransferase-dependent epigenetic repression of SATB1 was universally found in human Sézary syndrome, but not in other peripheral T cell malignancies. H3K27 and H3K9 trimethylation occluded the SATB1 promoter in Sézary cells, while inhibition of SUV39H1/2 methyltransferases (unlike EZH2 inhibition) restored protective SATB1 expression and selectively abrogated the growth of primary Sézary cells more effectively than romidepsin. Therefore, inhibition of methyltransferases that silence SATB1 could address an unmet need for patients with mycosis fungoides/Sézary syndrome, a set of incurable diseases.


Enzyme Inhibitors/pharmacology , Matrix Attachment Region Binding Proteins/metabolism , Methyltransferases/antagonists & inhibitors , Neoplasm Proteins , Sezary Syndrome/drug therapy , Skin Neoplasms/drug therapy , Animals , CD4-Positive T-Lymphocytes/metabolism , CD4-Positive T-Lymphocytes/pathology , CD8-Positive T-Lymphocytes/metabolism , CD8-Positive T-Lymphocytes/pathology , Cell Line, Tumor , Humans , Methyltransferases/metabolism , Mice , Mice, Transgenic , Neoplasm Proteins/antagonists & inhibitors , Neoplasm Proteins/metabolism , Sezary Syndrome/metabolism , Sezary Syndrome/pathology , Skin Neoplasms/metabolism , Skin Neoplasms/pathology
...